To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ITPRIPL2andSYT17TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
375 supporting clones for gene ITPRIPL2andSYT17 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB478429 hippocampus .a 1 to 447 1 to 447   tiling clone,   447/460
(97 %)
4 diff
(99.2 %id)
CN364006 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 37 to 600 1 to 564   tiling clone,   564/564
(100 %)
0 diff
(100 %id)
CA771529 Pancreas, Purified pancreatic islet .a 98 to 278 1 to 181       181/181
(100 %)
0 diff
(100 %id)
CA389452 eye, RPE/choroid .a 104 to 596 1 to 493       493/493
(100 %)
0 diff
(100 %id)
NM_016524.2   .a 104 to 2015 1 to 1912   RefSeq,   1912/1912
(100 %)
0 diff
(100 %id)
AW149485 brain, medulloblastoma .a 334 to 837 1 to 505     Submitted on the opposite strand 505/505
(100 %)
2 diff
(99.7 %id)
DT220986 brain .a 358 to 1017 1 to 660       660/660
(100 %)
1 diff
(99.9 %id)
BC004518 Lung, small cell carcinoma .a 425 to 1890 1 to 1466   available from MGC, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 1466/1466
(100 %)
1 diff
(100.0 %id)
BE798975 lung, small cell carcinoma .a 425 to 1275 35 to 873       839/941
(89 %)
22 diff
(97.7 %id)
AF220560   .a 427 to 1890 1 to 1464   tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 1464/1464
(100 %)
2 diff
(99.9 %id)
TI_1948146226   .a 429 to 1310 117 to 1007       891/1250
(71 %)
20 diff
(98.4 %id)
CV026444 mixed .a 435 to 1044 1 to 610       610/610
(100 %)
0 diff
(100 %id)
TI_1948146227   .a 435 to 904 117 to 588       472/1337
(35 %)
18 diff
(98.7 %id)
TI_1948146867   .a 435 to 991 126 to 687       562/1427
(39 %)
11 diff
(99.3 %id)
BF303864 muscle, rhabdomyosarcoma .a 509 to 1259 1 to 745       745/745
(100 %)
11 diff
(98.6 %id)
BQ070945 brain, neuroblastoma, cell line .a 531 to 1352 1 to 828   tiling clone,   828/1022
(81 %)
9 diff
(99.2 %id)
TI_1948146229   .a 935 to 1858 1051 to 129       923/1358
(67 %)
26 diff
(98.1 %id)
BP264924 muscle .a 952 to 1662 1 to 717       717/1011
(70 %)
11 diff
(99.0 %id)
TI_1948145920   .a 1060 to 1858 935 to 137       799/1425
(56 %)
35 diff
(97.6 %id)
TI_1948146870   .a 1080 to 1858 918 to 132       787/1492
(52 %)
24 diff
(98.4 %id)
BG055039 brain, glioblastoma (pooled) .a 1161 to 1890 723 to 1       723/723
(100 %)
21 diff
(97.1 %id)
AI363311 brain, glioblastoma (pooled) .a 1227 to 1890 664 to 1       664/664
(100 %)
9 diff
(98.7 %id)
BM714007 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1259 to 1840 1 to 582       582/582
(100 %)
0 diff
(100 %id)
TI_151753481   .a 1259 to 1890 707 to 71   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 637/1154
(55 %)
10 diff
(99.2 %id)
CK825300 insulinoma, Pancreas .a 1311 to 1853 543 to 1       543/543
(100 %)
4 diff
(99.3 %id)
BF196505 Kidney .a 1320 to 1890 571 to 1       571/571
(100 %)
0 diff
(100 %id)
BG913767 anaplastic oligodendroglioma with 1p/19qloss, brain .a 1356 to 2015 2 to 671   tiling clone,   670/671
(99 %)
11 diff
(98.4 %id)
TI_1948146173   .a 1383 to 1858 611 to 131       481/1496
(32 %)
23 diff
(98.5 %id)
TI_1948146228   .a 1383 to 1858 601 to 126       476/1348
(35 %)
2 diff
(99.9 %id)
CD519529 White Matter .a 1385 to 1890 1 to 506   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 506/506
(100 %)
9 diff
(98.3 %id)
BF942106 medullary carcinoma, thyroid .a 1392 to 1850 1 to 459     Submitted on the opposite strand 459/459
(100 %)
0 diff
(100 %id)
BF942273 medullary carcinoma, thyroid .a 1392 to 1861 1 to 467     Submitted on the opposite strand 467/470
(99 %)
4 diff
(99.2 %id)
CD557002 brain, Pituitary .a 1393 to 1890 1 to 497   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 497/497
(100 %)
5 diff
(99.0 %id)
AA789157   .a 1395 to 1892 497 to 1       497/497
(100 %)
2 diff
(99.6 %id)
BX106395 whole brain .a 1421 to 1904 484 to 1     Submitted on the opposite strand 484/484
(100 %)
0 diff
(100 %id)
AI948702 Kidney .a 1425 to 1890 466 to 1       466/466
(100 %)
9 diff
(98.1 %id)
BQ272543 insulinoma, Pancreas .a 1426 to 1905 480 to 1   tiling clone,   480/480
(100 %)
0 diff
(100 %id)
CA771221 Pancreas, Purified pancreatic islet .a 1445 to 1890 446 to 1       446/446
(100 %)
0 diff
(100 %id)
BG055966 anaplastic oligodendroglioma, brain .a 1476 to 1895 421 to 1       421/424
(99 %)
1 diff
(99.8 %id)
AW517032 cervix .a 1519 to 1890 371 to 1       371/372
(99 %)
1 diff
(99.8 %id)
BG055967 anaplastic oligodendroglioma, brain .a 1540 to 1854 316 to 1       316/364
(86 %)
17 diff
(95.4 %id)
AI287698 ovary, tumor, 5 pooled (see description) .a 1567 to 1892 328 to 1       328/329
(99 %)
3 diff
(99.1 %id)
AW136805   .a 1570 to 1890 338 to 18   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 321/321
(100 %)
0 diff
(100 %id)
AI033562 liver and spleen .a 1662 to 1891 230 to 1       230/230
(100 %)
2 diff
(99.2 %id)
CR595216 Neuroblastoma Cot 25-normalized .b 1 to 1695 1 to 1695   tiling clone,   1695/1695
(100 %)
0 diff
(100 %id)
AL523923 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 1 to 901 1 to 896   fully sequenced,   896/896
(100 %)
8 diff
(99.2 %id)
AL523922 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 871 to 1695 824 to 1   fully sequenced,   824/824
(100 %)
30 diff
(96.4 %id)
TI_154114048   .b 1262 to 1720 558 to 100   tiling clone, AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 459/460
(99 %)
1 diff
(99.8 %id)
CA448905 Chondrosarcoma, Left Pelvis .b 1282 to 1720 457 to 19   AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 439/439
(100 %)
1 diff
(99.8 %id)
NM_001034841.3   .c-u 1 to 7694 2 to 7695 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 7695/7695
(100 %)
0 diff
(100 %id)
BX382445 Placenta Cot 25-normalized .c-u 18 to 1034 1 to 1003   tiling clone,   1003/1062
(94 %)
17 diff
(98.4 %id)
BX335323 Placenta Cot 25-normalized .c-u 47 to 1014 1 to 964       964/964
(100 %)
5 diff
(99.5 %id)
BX338638 Placenta Cot 25-normalized .c-u 57 to 1030 1 to 967   tiling clone,   967/967
(100 %)
10 diff
(99.0 %id)
BX374951 Neuroblastoma Cot 25-normalized .c-u 78 to 937 1 to 859       859/859
(100 %)
3 diff
(99.7 %id)
CN280807 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c-u 162 to 495 1 to 334   tiling clone,   334/334
(100 %)
7 diff
(98.0 %id)
BC101749 Liver, PCR rescued clones .c-u 451 to 2188 1 to 1738 exact     1738/1738
(100 %)
0 diff
(100 %id)
BC101751 Liver, PCR rescued clones .c-u 451 to 2194 1 to 1744 exact tiling clone,   1744/1744
(100 %)
0 diff
(100 %id)
TI_927044854   .c-u 451 to 1195 46 to 793       748/895
(83 %)
23 diff
(97.5 %id)
TI_927044858   .c-u 451 to 1483 45 to 1074       1030/1201
(85 %)
4 diff
(99.7 %id)
TI_927044855   .c-u 451 to 1295 45 to 888       844/1059
(79 %)
19 diff
(98.3 %id)
TI_927044859   .c-u 451 to 1527 45 to 1121       1077/1233
(87 %)
10 diff
(99.2 %id)
AK097274 Spleen .c-u 554 to 2523 1 to 1970   tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 1970/1970
(100 %)
1 diff
(100.0 %id)
DA948521 Spleen .c-u 555 to 1116 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DB333655 Spleen .c-u 2060 to 2518 464 to 6       459/465
(98 %)
0 diff
(100 %id)
DA647282 mammary gland .d 1 to 809 2 to 807   tiling clone, capped   806/821
(98 %)
7 diff
(99.2 %id)
DB362149 mammary gland .d 1575 to 2082 508 to 1   tiling clone,   508/562
(90 %)
5 diff
(99.2 %id)
DN990237 brain, whole brain .e -10 to 531 1 to 542       542/542
(100 %)
5 diff
(99.1 %id)
AK098747 brain .e 1 to 1698 2 to 1699 exact tiling clone, available from FLJ,   1699/1699
(100 %)
0 diff
(100 %id)
BP312114 brain .e 1 to 575 2 to 579       579/582
(99 %)
7 diff
(98.8 %id)
DA188758 amygdala .e 1 to 539 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
DB482383 hippocampus .e 3 to 492 1 to 492       492/497
(98 %)
16 diff
(96.8 %id)
BI544621 brain, hippocampus .e 55 to 890 1 to 842       842/873
(96 %)
26 diff
(97.1 %id)
BG700238 brain, hippocampus .e 56 to 778 1 to 724       724/724
(100 %)
11 diff
(98.5 %id)
BI546853 brain, hippocampus .e 56 to 827 1 to 780       780/910
(85 %)
21 diff
(97.7 %id)
TI_44000791   .e 61 to 890 92 to 928       837/959
(87 %)
20 diff
(98.0 %id)
TI_44167278   .e 62 to 827 87 to 860       774/990
(78 %)
14 diff
(98.6 %id)
BQ267300 insulinoma, Pancreas .f 1 to 431 1 to 431   tiling clone,   431/431
(100 %)
5 diff
(98.9 %id)
CK825301 insulinoma, Pancreas .f 1 to 407 1 to 408       408/476
(85 %)
12 diff
(97.5 %id)
BQ548827 insulinoma, Pancreas .f 156 to 734 1 to 579   tiling clone,   579/579
(100 %)
3 diff
(99.5 %id)
TI_1948145917   .f 238 to 921 145 to 841   tiling clone,   697/1399
(49 %)
23 diff
(98.4 %id)
BQ548669 insulinoma, Pancreas .f 1220 to 1695 476 to 1   tiling clone,   476/476
(100 %)
0 diff
(100 %id)
Z41994 brain, total brain .g 1 to 281 1 to 281   tiling clone,   281/281
(100 %)
0 diff
(100 %id)
H23376 whole brain .g 2 to 352 1 to 351   tiling clone,   351/351
(100 %)
0 diff
(100 %id)
H23265 whole brain .g 1145 to 1502 362 to 1   tiling clone,   362/403
(89 %)
6 diff
(98.6 %id)
Z38280 brain, total brain .g 1218 to 1493 275 to 1       275/275
(100 %)
1 diff
(99.7 %id)
DA177295 amygdala .h 1 to 417 2 to 418   tiling clone, capped   417/418
(99 %)
2 diff
(99.6 %id)
AK296000 subthalamic nucleus .h 112 to 1690 1 to 1579 G125V tiling clone,   1579/1579
(100 %)
2 diff
(99.9 %id)
DC338322 subthalamic nucleus .h 112 to 660 1 to 549       549/549
(100 %)
0 diff
(100 %id)
BQ961069 sciatic nerve .h 1353 to 2197 1 to 852   tiling clone,   852/931
(91 %)
15 diff
(98.4 %id)
AW905079 nervous_normal .h 1686 to 2026 349 to 11   tiling clone,   339/372
(91 %)
0 diff
(100 %id)
BX088745 parathyroid gland, parathyroid tumor .h 1734 to 2438 1 to 706   tiling clone,   706/706
(100 %)
1 diff
(99.9 %id)
BP194748 brain .i 1 to 584 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
DC319904 brain .i 1 to 557 1 to 557   tiling clone,   557/557
(100 %)
1 diff
(99.9 %id)
DC320195 brain .i 7 to 530 1 to 524       524/525
(99 %)
1 diff
(99.9 %id)
BP350467 brain .i 72 to 660 1 to 588       588/588
(100 %)
1 diff
(99.9 %id)
BP200581 amygdala .i 87 to 668 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
DB470310 hippocampus .i 112 to 548 1 to 436       436/436
(100 %)
1 diff
(99.8 %id)
AW390432 stomach .i 186 to 531 346 to 1       346/355
(97 %)
13 diff
(96.4 %id)
BE792646 lung, small cell carcinoma .i 188 to 563 98 to 473       376/473
(79 %)
0 diff
(100 %id)
AA299960 uterus .i 204 to 528 1 to 325       325/325
(100 %)
3 diff
(99.1 %id)
AA372001 pituitary gland .i 244 to 565 1 to 322       322/322
(100 %)
0 diff
(100 %id)
AW963392   .i 245 to 909 1 to 663   tiling clone,   663/664
(99 %)
27 diff
(96.0 %id)
BE091672 breast .i 260 to 457 198 to 1     Submitted on the opposite strand 198/203
(97 %)
2 diff
(99.1 %id)
BG527236 lung, mucoepidermoid carcinoma .i 304 to 962 1 to 663   tiling clone,   663/812
(81 %)
11 diff
(98.7 %id)
AW856228 colon .i 719 to 1249 537 to 7   tiling clone,   531/552
(96 %)
2 diff
(99.7 %id)
AK096327   .j 1 to 2007 2 to 2008   available from FLJ,   2008/2008
(100 %)
0 diff
(100 %id)
NR_028028.1   .j 1 to 7178 2 to 7179   RefSeq, tiling clone, AAA   7179/7179
(100 %)
0 diff
(100 %id)
DA717408   .j 1 to 558 2 to 563   capped   562/562
(100 %)
5 diff
(99.2 %id)
DA373939 thalamus .j 74 to 635 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
TI_159701051   .j 178 to 1199 1039 to 51       989/1132
(87 %)
0 diff
(100 %id)
BX370145 Placenta Cot 25-normalized .j 219 to 801 1 to 588       588/1001
(58 %)
23 diff
(97.8 %id)
BF663645 B-cells, primary B-cells from tonsils (cell line) .j 259 to 892 1 to 632       632/886
(71 %)
14 diff
(98.5 %id)
BE247159 leukopheresis .j 283 to 687 1 to 405       405/405
(100 %)
0 diff
(100 %id)
AI791946 colon, colon tumor RER+ .j 327 to 801 1 to 475       475/475
(100 %)
0 diff
(100 %id)
AA293257 ovarian tumor, ovary .j 332 to 714 1 to 373       373/373
(100 %)
11 diff
(97.1 %id)
AI732650 colon, colon tumor RER+ .j 651 to 1173 523 to 1       523/523
(100 %)
3 diff
(99.5 %id)
AA256841 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j 660 to 971 1 to 308   fully sequenced,   308/308
(100 %)
3 diff
(99.1 %id)
TI_157612401   .j 667 to 1197 605 to 70       536/616
(87 %)
0 diff
(100 %id)
BF112168 pooled .j 673 to 1197 526 to 1       526/526
(100 %)
2 diff
(99.7 %id)
AA576821 colon, colon tumor RER+ .j 683 to 1171 486 to 1       486/486
(100 %)
3 diff
(99.4 %id)
AW451088   .j 693 to 1196 505 to 1       505/505
(100 %)
4 diff
(99.3 %id)
AW451113   .j 709 to 1196 488 to 1       488/488
(100 %)
3 diff
(99.4 %id)
AI793161 adenocarcinoma, colon .j 710 to 1168 1 to 460       460/462
(99 %)
2 diff
(99.6 %id)
AA928730 adenocarcinoma, colon .j 743 to 1193 447 to 3       445/447
(99 %)
0 diff
(100 %id)
AI858639 anaplastic oligodendroglioma, brain .j 759 to 1173 415 to 1       415/415
(100 %)
1 diff
(99.8 %id)
AI733225 adenocarcinoma, colon .j 763 to 1173 412 to 1       412/412
(100 %)
3 diff
(99.3 %id)
BF591036 colon, colon tumor, RER+ .j 769 to 1196 428 to 1       428/428
(100 %)
6 diff
(98.6 %id)
AW451977   .j 772 to 1196 425 to 1       425/425
(100 %)
0 diff
(100 %id)
AA737668 germinal center B cell .j 785 to 1168 383 to 1       383/383
(100 %)
3 diff
(99.3 %id)
BF514942   .j 789 to 1196 408 to 1       408/422
(96 %)
0 diff
(100 %id)
AW026614 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .j 804 to 1181 378 to 1       378/378
(100 %)
6 diff
(98.5 %id)
AI283310 ovary, tumor, 5 pooled (see description) .j 806 to 1181 376 to 1       376/376
(100 %)
0 diff
(100 %id)
BX404320 neuroblastoma .j 852 to 1197 346 to 1       346/346
(100 %)
1 diff
(99.8 %id)
BE464392 Kidney .j 862 to 1197 336 to 1       336/336
(100 %)
0 diff
(100 %id)
AI953570 Kidney .j 867 to 1173 307 to 1       307/307
(100 %)
1 diff
(99.7 %id)
AI424236 Prostate .j 872 to 1173 302 to 1       302/302
(100 %)
0 diff
(100 %id)
AW471156 colon, moderately-differentiated adenocarcinoma .j 912 to 1197 287 to 2       286/287
(99 %)
0 diff
(100 %id)
AA256430 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j 941 to 1174 235 to 1   fully sequenced,   235/235
(100 %)
4 diff
(98.3 %id)
TI_927046646   .j 947 to 1684 1 to 738       738/1271
(58 %)
8 diff
(99.4 %id)
TI_927047179   .j 948 to 1678 1 to 731       731/1075
(68 %)
6 diff
(99.5 %id)
TI_927047175   .j 950 to 1684 5 to 739       735/1090
(67 %)
9 diff
(99.2 %id)
TI_927046652   .j 958 to 1678 12 to 731       720/1252
(57 %)
2 diff
(99.9 %id)
BM792354 Ascites, stomach .j 1101 to 1388 1 to 289       289/291
(99 %)
22 diff
(92.5 %id)
N34341 melanocyte .j 1189 to 1642 1 to 455     Submitted on the opposite strand 455/455
(100 %)
10 diff
(97.9 %id)
AA430466 ovarian tumor, ovary .j 1189 to 1674 1 to 482     Submitted on the opposite strand 482/482
(100 %)
8 diff
(98.4 %id)
AA011094 heart .j 1190 to 1531 1 to 346     Submitted on the opposite strand 346/418
(82 %)
10 diff
(97.7 %id)
AA281105 germinal center B cell .j 1190 to 1533 1 to 344     Submitted on the opposite strand 344/344
(100 %)
4 diff
(98.9 %id)
AA430410 ovarian tumor, ovary .j 1190 to 1681 1 to 491     Submitted on the opposite strand 491/491
(100 %)
9 diff
(98.2 %id)
AA553676 colon .j 1190 to 1568 1 to 379     Submitted on the opposite strand 379/379
(100 %)
0 diff
(100 %id)
AA877578 colon, colon tumor RER+ .j 1190 to 1708 1 to 519     Submitted on the opposite strand 519/519
(100 %)
8 diff
(98.5 %id)
AA911831 adenocarcinoma, colon .j 1190 to 1569 1 to 376     Submitted on the opposite strand 376/376
(100 %)
13 diff
(96.6 %id)
AA975503 pooled .j 1190 to 1680 1 to 487     Submitted on the opposite strand 487/496
(98 %)
10 diff
(98.0 %id)
AI198195 anaplastic oligodendroglioma, brain .j 1190 to 1634 1 to 443     Submitted on the opposite strand 443/443
(100 %)
6 diff
(98.7 %id)
BF475690 Prostate .j 1190 to 1579 1 to 390     Submitted on the opposite strand 390/390
(100 %)
1 diff
(99.8 %id)
BF432111 pooled .j 1190 to 1699 1 to 510     Submitted on the opposite strand 510/510
(100 %)
0 diff
(100 %id)
BF111702 pooled .j 1190 to 1379 1 to 190     Submitted on the opposite strand 190/190
(100 %)
0 diff
(100 %id)
TI_157598347   .j 1190 to 1929 56 to 783     Submitted on the opposite strand 728/1022
(71 %)
18 diff
(98.3 %id)
TI_157602330   .j 1190 to 1766 76 to 656     Submitted on the opposite strand 581/1051
(55 %)
0 diff
(100 %id)
TI_157602796   .j 1190 to 1637 77 to 522     Submitted on the opposite strand 446/925
(48 %)
3 diff
(99.7 %id)
TI_157603464   .j 1190 to 1920 85 to 807     Submitted on the opposite strand 723/963
(75 %)
16 diff
(98.4 %id)
TI_157604181   .j 1190 to 1706 85 to 601     Submitted on the opposite strand 517/1122
(46 %)
12 diff
(99.0 %id)
TI_157607442   .j 1190 to 1755 77 to 647     Submitted on the opposite strand 571/1157
(49 %)
12 diff
(99.0 %id)
AA993935 pooled .j 1191 to 1393 1 to 198     Submitted on the opposite strand 198/198
(100 %)
8 diff
(96.0 %id)
AW016264   .j 1191 to 1582 1 to 392     Submitted on the opposite strand 392/392
(100 %)
3 diff
(99.3 %id)
R68456 placenta .j 1198 to 1483 1 to 285     Submitted on the opposite strand 285/285
(100 %)
8 diff
(97.2 %id)
N20871 melanocyte .j 1206 to 1680 17 to 504     Submitted on the opposite strand 488/537
(90 %)
19 diff
(96.5 %id)
N26054 melanocyte .j 1214 to 1745 1 to 537     Submitted on the opposite strand 537/561
(95 %)
23 diff
(96.0 %id)
N33239 melanocyte .j 1214 to 1527 1 to 312     Submitted on the opposite strand 312/312
(100 %)
7 diff
(97.8 %id)
N33421 melanocyte .j 1214 to 1500 1 to 284     Submitted on the opposite strand 284/284
(100 %)
8 diff
(97.2 %id)
N25200 melanocyte .j 1215 to 1667 1 to 438     Submitted on the opposite strand 438/442
(99 %)
34 diff
(92.4 %id)
AA897724 pooled .j 1215 to 1373 1 to 159     Submitted on the opposite strand 159/159
(100 %)
2 diff
(98.8 %id)
AI144396 heart .j 1215 to 1677 1 to 463     Submitted on the opposite strand 463/463
(100 %)
0 diff
(100 %id)
AI309919 adenocarcinoma, colon .j 1215 to 1588 1 to 374     Submitted on the opposite strand 374/374
(100 %)
1 diff
(99.8 %id)
AI202298 Prostate .j 1215 to 1489 1 to 275     Submitted on the opposite strand 275/275
(100 %)
0 diff
(100 %id)
AI201744 Prostate .j 1215 to 1661 1 to 447     Submitted on the opposite strand 447/447
(100 %)
0 diff
(100 %id)
AI338680 lung .j 1215 to 1662 1 to 448     Submitted on the opposite strand 448/448
(100 %)
2 diff
(99.6 %id)
AI377935 pooled .j 1215 to 1665 1 to 451     Submitted on the opposite strand 451/458
(98 %)
3 diff
(99.4 %id)
AI458417 pooled .j 1215 to 1939 1 to 723     Submitted on the opposite strand 723/1133
(63 %)
15 diff
(98.7 %id)
AI570714 anaplastic oligodendroglioma, brain .j 1215 to 1672 1 to 458     Submitted on the opposite strand 458/458
(100 %)
0 diff
(100 %id)
AI913092 Kidney .j 1215 to 1664 1 to 448     Submitted on the opposite strand 448/448
(100 %)
3 diff
(99.4 %id)
AA883429 pooled .j 1216 to 1686 1 to 468     Submitted on the opposite strand 468/468
(100 %)
9 diff
(98.1 %id)
AA860553 parathyroid gland, parathyroid tumor .j 1217 to 1608 1 to 389     Submitted on the opposite strand 389/389
(100 %)
9 diff
(97.7 %id)
AI143663 anaplastic oligodendroglioma, brain .j 1217 to 1375 1 to 159     Submitted on the opposite strand 159/159
(100 %)
2 diff
(98.8 %id)
AW665107 pooled .j 1225 to 1395 1 to 171     Submitted on the opposite strand 171/171
(100 %)
0 diff
(100 %id)
BF114685 pooled .j 1238 to 1756 1 to 519     Submitted on the opposite strand 519/519
(100 %)
4 diff
(99.3 %id)
AA824544 germinal center B cell .j 1242 to 1477 1 to 235       235/235
(100 %)
8 diff
(96.6 %id)
AI825997 normal prostate, Prostate .j 1242 to 1456 1 to 215     Submitted on the opposite strand 215/215
(100 %)
0 diff
(100 %id)
TI_927046651   .j 1247 to 1678 1 to 429       429/1235
(34 %)
6 diff
(99.6 %id)
H82086 melanocyte .j 1247 to 1547 1 to 308     Submitted on the opposite strand 308/308
(100 %)
15 diff
(95.2 %id)
TI_927047174   .j 1248 to 1684 5 to 439       435/1118
(38 %)
9 diff
(99.2 %id)
H96888 melanocyte .j 1248 to 1633 1 to 392     Submitted on the opposite strand 392/392
(100 %)
13 diff
(96.7 %id)
TI_927046645   .j 1253 to 1684 10 to 440       431/1213
(35 %)
5 diff
(99.6 %id)
AA748392 germinal center B cell .j 1256 to 1600 1 to 345     Submitted on the opposite strand 345/345
(100 %)
3 diff
(99.2 %id)
AA768845 germinal center B cell .j 1257 to 1931 1 to 679     Submitted on the opposite strand 679/889
(76 %)
34 diff
(96.2 %id)
AA743530 germinal center B cell .j 1259 to 1641 1 to 382     Submitted on the opposite strand 382/382
(100 %)
5 diff
(98.7 %id)
AA669119 germinal center B cell .j 1263 to 1720 1 to 455     Submitted on the opposite strand 455/455
(100 %)
4 diff
(99.2 %id)
AA854894 parathyroid gland, parathyroid tumor .j 1266 to 1627 1 to 359     Submitted on the opposite strand 359/359
(100 %)
5 diff
(98.7 %id)
AA830441 germinal center B cell .j 1277 to 1601 1 to 323     Submitted on the opposite strand 323/323
(100 %)
9 diff
(97.3 %id)
BQ773852 Chondrosarcoma Grade II, Left Pelvis .j 1354 to 2025 671 to 1       671/671
(100 %)
2 diff
(99.8 %id)
CA396105 eye, RPE/choroid .j 1356 to 1848 1 to 493       493/493
(100 %)
0 diff
(100 %id)
BX108029 heart .j 1440 to 2091 654 to 4     Submitted on the opposite strand 651/654
(99 %)
0 diff
(100 %id)
N36071 melanocyte .j 1473 to 2002 539 to 1     Submitted on the opposite strand 539/541
(99 %)
12 diff
(97.8 %id)
AA746275 germinal center B cell .j 1488 to 1691 201 to 1     Submitted on the opposite strand 201/201
(100 %)
3 diff
(98.6 %id)
DB324187   .j 1491 to 2007 517 to 1       517/517
(100 %)
0 diff
(100 %id)
N27713 melanocyte .j 1530 to 2022 504 to 8     Submitted on the opposite strand 497/505
(98 %)
0 diff
(100 %id)
N42396 melanocyte .j 1532 to 1966 435 to 1     Submitted on the opposite strand 435/435
(100 %)
1 diff
(99.8 %id)
BG990652 head_neck .j 1561 to 2005 6 to 456       451/456
(98 %)
0 diff
(100 %id)
AA430639 ovarian tumor, ovary .j 1561 to 2002 442 to 1     Submitted on the opposite strand 442/443
(99 %)
2 diff
(99.6 %id)
N41954 melanocyte .j 1568 to 2002 440 to 1     Submitted on the opposite strand 440/527
(83 %)
12 diff
(97.8 %id)
N40418 melanocyte .j 1577 to 2008 434 to 1     Submitted on the opposite strand 434/434
(100 %)
2 diff
(99.6 %id)
N42576 melanocyte .j 1578 to 2013 439 to 1     Submitted on the opposite strand 439/441
(99 %)
3 diff
(99.4 %id)
H82193 melanocyte .j 1683 to 2009 330 to 1     Submitted on the opposite strand 330/330
(100 %)
3 diff
(99.1 %id)
AA582985 larynx .j 1705 to 1995 291 to 1       291/291
(100 %)
0 diff
(100 %id)
BE005924 breast_normal .j 1764 to 2451 686 to 2     Submitted on the opposite strand 685/686
(99 %)
12 diff
(98.3 %id)
AI971538 pooled germ cell tumors .j 1771 to 2080 340 to 31   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 310/310
(100 %)
13 diff
(95.9 %id)
CU448832 epidermis .j 1773 to 2200 442 to 16     Submitted on the opposite strand 427/444
(96 %)
0 diff
(100 %id)
BE005988 breast_normal .j 1782 to 2451 665 to 1     Submitted on the opposite strand 665/667
(99 %)
11 diff
(98.4 %id)
AA011093 heart .j 1792 to 2080 290 to 1     Submitted on the opposite strand 290/294
(98 %)
9 diff
(97.0 %id)
BQ358877 head_neck .j 1821 to 2156 343 to 6       338/343
(98 %)
0 diff
(100 %id)
CU447631 epidermis .j 1933 to 2708 7 to 783       777/783
(99 %)
0 diff
(100 %id)
R68455 placenta .j 1993 to 2404 421 to 1     Submitted on the opposite strand 421/439
(95 %)
22 diff
(95.0 %id)
CU455281 epidermis .j 2009 to 2794 797 to 13     Submitted on the opposite strand 785/797
(98 %)
0 diff
(100 %id)
AA410535 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j 2045 to 2436 1 to 391       391/391
(100 %)
4 diff
(99.0 %id)
BG897097 cartilage .j 2075 to 2586 86 to 597       512/529
(96 %)
0 diff
(100 %id)
BE002908 breast_normal .j 2405 to 2900 495 to 3     Submitted on the opposite strand 493/495
(99 %)
0 diff
(100 %id)
BG897840 cartilage .j 2504 to 2961 51 to 508       458/508
(90 %)
0 diff
(100 %id)
BG109333 Bone, osteosarcoma, cell line .j 2583 to 3357 1 to 769       769/942
(81 %)
20 diff
(97.9 %id)
H62860 liver and spleen .j 2675 to 3035 1 to 368     Submitted on the opposite strand 368/372
(98 %)
8 diff
(97.9 %id)
BM194041 leukopheresis .j 2797 to 3292 496 to 1       496/496
(100 %)
2 diff
(99.6 %id)
DW432681 Liver .j 2892 to 3140 17 to 265       249/265
(93 %)
0 diff
(100 %id)
DW432682 Liver .j 2892 to 3140 17 to 265       249/265
(93 %)
0 diff
(100 %id)
BU509171 leiomyosarcoma, uterus .j 2921 to 3670 36 to 790       755/888
(85 %)
18 diff
(98.0 %id)
BE247184 leukopheresis .j 2946 to 3292 347 to 1       347/349
(99 %)
0 diff
(100 %id)
AL047552 uterus .j 3082 to 3335 20 to 273       254/273
(93 %)
0 diff
(100 %id)
AI023147 senescent fibroblast .j 3097 to 3226 141 to 12   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 130/130
(100 %)
0 diff
(100 %id)
AW800613 uterus .j 3177 to 3497 733 to 424       310/740
(41 %)
0 diff
(100 %id)
BX103506 breast .j 3195 to 3673 1 to 480       480/804
(59 %)
5 diff
(99.4 %id)
BM799306 Ascites, stomach .j 3195 to 3731 1 to 537       537/537
(100 %)
0 diff
(100 %id)
EH345731   .j 3259 to 3334 1 to 76       76/76
(100 %)
0 diff
(100 %id)
BQ773990 Bone, Human Chondrosarcoma Cell Line .j 3320 to 4016 715 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 697/697
(100 %)
8 diff
(98.9 %id)
TI_154151822   .j 3355 to 4030 749 to 80     Submitted on the opposite strand 670/671
(99 %)
27 diff
(96.0 %id)
TI_154154276   .j 3395 to 4033 734 to 96     Submitted on the opposite strand 639/656
(97 %)
0 diff
(100 %id)
AW500161 lymph .j 3465 to 4033 592 to 24     Submitted on the opposite strand 569/592
(96 %)
0 diff
(100 %id)
H67608 liver and spleen .j 3476 to 3877 412 to 1     Submitted on the opposite strand 412/456
(90 %)
24 diff
(94.8 %id)
BU430408 lymph .j 3529 to 4030 509 to 8     Submitted on the opposite strand 502/509
(98 %)
0 diff
(100 %id)
CD721916 eye, lacrimal gland .j 3550 to 4189 1 to 641       641/641
(100 %)
1 diff
(99.9 %id)
AL047553 uterus .j 3566 to 3988 466 to 45   AAA   422/455
(92 %)
0 diff
(100 %id)
H62980 liver and spleen .j 3584 to 3877 293 to 1     Submitted on the opposite strand 293/293
(100 %)
12 diff
(96.0 %id)
AI926033 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .j 3635 to 4017 383 to 1       383/383
(100 %)
1 diff
(99.8 %id)
BM801397 duodenal adenocarcinoma, cell line, small intestine .j 3705 to 4238 1 to 536       536/974
(55 %)
6 diff
(99.4 %id)
AK024121 whole embryo, mainly body .j 3797 to 4559 833 to 1601   available from FLJ,   769/1601
(48 %)
0 diff
(100 %id)
BF082054 breast_normal .j 3985 to 4445 471 to 6       466/518
(89 %)
0 diff
(100 %id)
TI_149275040   .j 3986 to 4559 660 to 85   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 576/996
(57 %)
1 diff
(99.9 %id)
BU676504 lung, Primary Lung Epithelial Cells .j 3986 to 4559 594 to 19   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 576/711
(81 %)
1 diff
(99.9 %id)
AI766311 Kidney .j 4043 to 4559 517 to 1       517/517
(100 %)
2 diff
(99.7 %id)
AI690296 carcinoid, lung .j 4054 to 4558 505 to 1       505/505
(100 %)
2 diff
(99.7 %id)
AI160709 placenta .j 4067 to 4559 493 to 1       493/493
(100 %)
0 diff
(100 %id)
AU146463 whole embryo, mainly body .j 4081 to 4554 487 to 6       482/494
(97 %)
0 diff
(100 %id)
BE327735 carcinoid, lung .j 4104 to 4558 455 to 1       455/455
(100 %)
2 diff
(99.6 %id)
BG107571 Bone, osteosarcoma, cell line .j 4105 to 4827 26 to 737       712/737
(96 %)
0 diff
(100 %id)
AA927306 pooled .j 4106 to 4559 454 to 1       454/454
(100 %)
0 diff
(100 %id)
BE671528 carcinoid, lung .j 4141 to 4562 422 to 1       422/422
(100 %)
1 diff
(99.8 %id)
AA045399 uterus .j 4150 to 4615 1 to 468       468/473
(98 %)
9 diff
(98.1 %id)
BG576884 breast, mammary adenocarcinoma, cell line .j 4156 to 4559 11 to 414   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 404/414
(97 %)
0 diff
(100 %id)
AA988888 carcinoid, lung .j 4197 to 4558 362 to 1       362/362
(100 %)
0 diff
(100 %id)
BF110139 carcinoid, lung .j 4252 to 4562 311 to 1       311/326
(95 %)
7 diff
(97.9 %id)
AA708933 uterus .j 4253 to 4559 307 to 1       307/307
(100 %)
0 diff
(100 %id)
BE828278 lung_tumor .j 4290 to 4766 19 to 493       475/496
(95 %)
9 diff
(98.2 %id)
BI858381 breast, mammary adenocarcinoma, cell line .j 4350 to 4951 1 to 609       609/886
(68 %)
16 diff
(98.2 %id)
TI_57187011   .j 4350 to 4951 53 to 661       609/886
(68 %)
16 diff
(98.2 %id)
AW800629 uterus .j 4537 to 4759 228 to 6       223/234
(95 %)
0 diff
(100 %id)
CA424519 cell lines, Chondrosarcoma .j 4539 to 5278 753 to 16   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 738/738
(100 %)
2 diff
(99.8 %id)
BC015343 Breast, mammary adenocarcinoma. .j 4547 to 5275 17 to 745   available from MGC, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 729/729
(100 %)
0 diff
(100 %id)
BG032539 breast, mammary adenocarcinoma, cell line .j 4547 to 5185 28 to 668   available from MGC,   641/745
(86 %)
4 diff
(99.5 %id)
AW890772 nervous_tumor .j 4552 to 4867 22 to 338       317/348
(91 %)
9 diff
(97.5 %id)
AW890774 nervous_tumor .j 4556 to 4867 21 to 333       313/343
(91 %)
6 diff
(98.3 %id)
BQ017813 Chondrosarcoma, Left Pubic Bone .j 4563 to 5278 731 to 16   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 716/716
(100 %)
2 diff
(99.8 %id)
BF773527 epid_tumor .j 4649 to 4819 197 to 22     Submitted on the opposite strand 176/197
(89 %)
0 diff
(100 %id)
AW849893 colon .j 4703 to 4912 1 to 210       210/210
(100 %)
1 diff
(99.6 %id)
AW203992   .j 4710 to 5233 12 to 535     Submitted on the opposite strand 524/535
(97 %)
0 diff
(100 %id)
TI_153987637   .j 4710 to 5253 78 to 621     Submitted on the opposite strand 544/621
(87 %)
0 diff
(100 %id)
AA631997 breast .j 4738 to 5272 535 to 1       535/535
(100 %)
0 diff
(100 %id)
AJ708012 heart .j 4748 to 5080 16 to 348       333/348
(95 %)
0 diff
(100 %id)
AI570451 anaplastic oligodendroglioma, brain .j 4826 to 5275 450 to 1       450/450
(100 %)
0 diff
(100 %id)
AA632162 breast .j 4878 to 5272 395 to 1       395/395
(100 %)
0 diff
(100 %id)
G36733   .j 4933 to 5273 342 to 1     Submitted on the opposite strand 342/342
(100 %)
3 diff
(99.2 %id)
AA045083 uterus .j 4933 to 5273 342 to 1       342/342
(100 %)
3 diff
(99.2 %id)
AA515633 liposarcoma .j 4981 to 5283 303 to 1       303/303
(100 %)
2 diff
(99.4 %id)
AI916551 Kidney .j 4996 to 5274 281 to 3       279/281
(99 %)
0 diff
(100 %id)
CN278976 embryonic stem cells, cell lines H1, H7, andH9 .j 5006 to 5275 1 to 270   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 270/270
(100 %)
0 diff
(100 %id)
AA746140 Kidney .j 5008 to 5275 268 to 1       268/268
(100 %)
0 diff
(100 %id)
Z21602   .j 5013 to 5221 20 to 227       208/227
(91 %)
0 diff
(100 %id)
BF981594 duodenal adenocarcinoma, cell line, small intestine .j 5024 to 5568 1 to 568       568/1274
(44 %)
65 diff
(94.9 %id)
BI224317 cervical carcinoma cell line, cervix .j 5097 to 5808 1 to 719       719/811
(88 %)
38 diff
(95.4 %id)
CN278977 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .j 5126 to 5851 1 to 727       727/727
(100 %)
4 diff
(99.5 %id)
AA779493   .j 5147 to 5282 137 to 1       137/137
(100 %)
1 diff
(99.3 %id)
FN084375 breast carcinoma .j 5156 to 5223 68 to 1     Submitted on the opposite strand 68/68
(100 %)
0 diff
(100 %id)
FN120375 breast carcinoma .j 5200 to 5268 1 to 69       69/76
(90 %)
1 diff
(98.7 %id)
FN163923 breast carcinoma .j 5481 to 5603 1 to 116       116/116
(100 %)
5 diff
(95.7 %id)
BM556801 duodenal adenocarcinoma, cell line, small intestine .j 5596 to 6457 1 to 860       860/1033
(83 %)
22 diff
(97.9 %id)
AA346520 heart .j 5806 to 6146 1 to 338       338/339
(99 %)
5 diff
(98.6 %id)
BG286483 bladder, transitional cell papilloma, cell line .j 6054 to 6174 466 to 592       519/1130
(45 %)
25 diff
(97.8 %id)
CA428849 Bone, Subchondral Bone .j 6178 to 6823 664 to 19   AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 646/646
(100 %)
2 diff
(99.7 %id)
BF434421 fibrotheoma, ovary .j 6193 to 6715 1 to 523     Submitted on the opposite strand 523/523
(100 %)
0 diff
(100 %id)
CN288775 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .j 6276 to 6609 1 to 334       334/334
(100 %)
3 diff
(99.2 %id)
BE185921 head_neck .j 6371 to 6647 15 to 291       277/291
(95 %)
0 diff
(100 %id)
AA357394 Kidney .j 6391 to 6716 1 to 327       327/327
(100 %)
5 diff
(98.5 %id)
AW965828   .j 6392 to 6983 1 to 589       589/590
(99 %)
17 diff
(97.2 %id)
BF085972 placenta_normal .j 6431 to 6659 1 to 230       230/246
(93 %)
5 diff
(98.0 %id)
AW302471 brain, three pooled meningiomas .j 6467 to 6823 357 to 1       357/357
(100 %)
0 diff
(100 %id)
AI673636 colon, colonic mucosa from 3 patients with Crohn'sdisease .j 6472 to 6843 386 to 14       373/386
(96 %)
0 diff
(100 %id)
CA427626 Bone, Subchondral Bone .j 6494 to 7178 703 to 19   AAA   685/685
(100 %)
0 diff
(100 %id)
TI_154021143   .j 6502 to 7178 765 to 89   AAA   677/679
(99 %)
25 diff
(96.4 %id)
EH339296   .j 6547 to 6640 1 to 93       93/93
(100 %)
2 diff
(97.9 %id)
BI256833 cervical carcinoma cell line, cervix .j 6591 to 7160 1 to 580       580/884
(65 %)
35 diff
(96.1 %id)
BF433462 carcinoid, lung .j 6610 to 6886 1 to 277     Submitted on the opposite strand 277/277
(100 %)
3 diff
(99.0 %id)
AA490463 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j 6618 to 6925 1 to 310     Submitted on the opposite strand 310/310
(100 %)
3 diff
(99.1 %id)
AI214598 carcinoid, lung .j 6648 to 7070 1 to 423     Submitted on the opposite strand 423/423
(100 %)
2 diff
(99.6 %id)
BE222277 carcinoid, lung .j 6651 to 7133 1 to 483     Submitted on the opposite strand 483/483
(100 %)
2 diff
(99.6 %id)
BG116542 duodenal adenocarcinoma, cell line, small intestine .j 6699 to 7182 1 to 484   AAA   484/484
(100 %)
3 diff
(99.4 %id)
AI984768 Kidney .j 6756 to 7177 423 to 1       423/423
(100 %)
7 diff
(98.4 %id)
AA527740 Prostate .j 6773 to 7160 1 to 388       388/389
(99 %)
7 diff
(98.3 %id)
AI753700 bone marrow stroma .j 6775 to 7178 431 to 28   AAA   404/404
(100 %)
0 diff
(100 %id)
AI417662 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j 6810 to 7181 374 to 4       371/374
(99 %)
0 diff
(100 %id)
AA651751 normal prostate, Prostate .j 6827 to 7178 1 to 352   fully sequenced, AAA   352/352
(100 %)
0 diff
(100 %id)
AI537648 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .j 6872 to 7181 316 to 7       310/316
(98 %)
0 diff
(100 %id)
AK026647   .j 6920 to 7178 1 to 259   available from FLJ, AAA   259/259
(100 %)
0 diff
(100 %id)
AA410310 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j 6963 to 7181 222 to 4       219/222
(98 %)
0 diff
(100 %id)
AI915016 ovary, tumor, 5 pooled (see description) .j 6974 to 7178 223 to 19   AAA   205/205
(100 %)
1 diff
(99.6 %id)
FN049083 breast carcinoma .j 6994 to 7101 1 to 108       108/108
(100 %)
0 diff
(100 %id)
AA628084 normal prostate, Prostate .j 7004 to 7178 175 to 1   fully sequenced,   175/175
(100 %)
0 diff
(100 %id)
FN160757 breast carcinoma .j 7092 to 7181 1 to 87       87/90
(96 %)
5 diff
(94.5 %id)
BP309393 brain .k 1 to 580 1 to 582 E99G F182X G183W L185F K188P ... tiling clone,   582/582
(100 %)
3 diff
(99.5 %id)
DC314391 amygdala .l 1 to 551 1 to 551 exact tiling clone,   551/551
(100 %)
1 diff
(99.9 %id)
BP192720 brain .m 1 to 579 1 to 582 F136X G137W V138R L139S S140Q ... tiling clone,   582/582
(100 %)
3 diff
(99.5 %id)
BG341359 B-cells, primary B-cells from tonsils (cell line) .n 1 to 782 1 to 768 T68N K69Q K70E T71D S72V ... tiling clone, AAA   768/880
(87 %)
27 diff
(97.0 %id)
AA769035 germinal center B cell .n 42 to 488 10 to 455   tiling clone, Submitted on the opposite strand 446/447
(99 %)
4 diff
(99.2 %id)
AI914047 carcinoid, lung .n 67 to 459 1 to 393     Submitted on the opposite strand 393/393
(100 %)
1 diff
(99.8 %id)
DA175902 amygdala .o 1 to 563 2 to 564 exact tiling clone, capped   563/563
(100 %)
1 diff
(99.9 %id)
DB471091 hippocampus .p 1 to 473 1 to 472 G27R A117D tiling clone,   472/475
(99 %)
5 diff
(99.0 %id)
DB475713 hippocampus .p 1 to 489 1 to 489 G27R tiling clone,   489/489
(100 %)
2 diff
(99.6 %id)
DA148573 amygdala .q-u 1 to 567 2 to 568   tiling clone, capped   567/567
(100 %)
1 diff
(99.9 %id)
DA595766 lung .q-u 293 to 858 2 to 566 exact tiling clone, capped   565/565
(100 %)
1 diff
(99.9 %id)
AI140528 liver and spleen .q-u 649 to 1039 391 to 1   tiling clone,   391/391
(100 %)
1 diff
(99.8 %id)
AW514123 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .q-u 757 to 1039 283 to 1   tiling clone,   283/283
(100 %)
2 diff
(99.3 %id)
AV751842 Pituitary .q-u 1290 to 1913 1 to 625   tiling clone,   625/717
(87 %)
11 diff
(98.5 %id)
TI_149302217   .q-u 1298 to 2264 1016 to 77   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 940/986
(95 %)
34 diff
(96.6 %id)
AA250917 germinal center B cell .q-u 1324 to 1491 1 to 168   tiling clone, Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 168/168
(100 %)
0 diff
(100 %id)
BF890696 marrow .q-u 1461 to 1888 1 to 428       428/439
(97 %)
7 diff
(98.5 %id)
TI_149296919   .q-u 1495 to 2260 848 to 87   tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 762/908
(83 %)
7 diff
(99.3 %id)
BM980456 lung, Primary Lung Cystic Fibrosis EpithelialCells .q-u 1579 to 2264 700 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 682/682
(100 %)
4 diff
(99.5 %id)
BM982070 lung, Primary Lung Cystic Fibrosis EpithelialCells .q-u 1583 to 2260 696 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 678/678
(100 %)
0 diff
(100 %id)
DB301598 amygdala .q-u 1723 to 2264 542 to 1   tiling clone,   542/542
(100 %)
0 diff
(100 %id)
AW971541   .q-u 1731 to 2260 532 to 2     Submitted on the opposite strand 531/532
(99 %)
0 diff
(100 %id)
CV342614 kidney_tumor .q-u 1766 to 1942 1 to 179       179/186
(96 %)
10 diff
(94.7 %id)
AI654652 ovary, tumor, 5 pooled (see description) .q-u 1831 to 2263 433 to 1       433/433
(100 %)
0 diff
(100 %id)
AW512260 lymph node, lymphoma, follicular mixed small and largecell .q-u 1840 to 2260 461 to 41   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 421/421
(100 %)
3 diff
(99.3 %id)
DB532648 hippocampus .q-u 1842 to 2264 1 to 423     Submitted on the opposite strand 423/423
(100 %)
1 diff
(99.8 %id)
AI569111 adenocarcinoma, Pancreas .q-u 1860 to 2263 405 to 2       404/405
(99 %)
0 diff
(100 %id)
AA705977 parathyroid gland, parathyroid tumor .q-u 1867 to 2264 409 to 13   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 397/397
(100 %)
3 diff
(99.3 %id)
AI302060 carcinoid, lung .q-u 1868 to 2264 397 to 1       397/397
(100 %)
1 diff
(99.8 %id)
AA253461 germinal center B cell .q-u 1906 to 2260 365 to 11   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 355/355
(100 %)
0 diff
(100 %id)
BP398326 pancreatic islet .q-u 1909 to 2260 1 to 347     Submitted on the opposite strand 347/347
(100 %)
10 diff
(97.2 %id)
AI568084 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .q-u 2043 to 2263 221 to 1       221/221
(100 %)
0 diff
(100 %id)
AW518492 lymph node, lymphoma, follicular mixed small and largecell .r-u 1 to 374 376 to 1 exact tiling clone,   376/376
(100 %)
4 diff
(99.0 %id)
DB329018 placenta Gene ITPRIPL2andSYT17, variant not shown         This clone was ignored    
DA860272 placenta Gene ITPRIPL2andSYT17, variant not shown       capped This clone was ignored    
BX351188 Neuroblastoma Cot 25-normalized Gene ITPRIPL2andSYT17, variant not shown         Internal priming: the 3' end of the oligo dT primed clone lies in the CDS, this clone was ignored    
BX394959 Neuroblastoma Cot 25-normalized Gene ITPRIPL2andSYT17, variant not shown         Internal priming: the 3' end of the oligo dT primed clone lies in the CDS, this clone was ignored    
AV750922 Pituitary Gene ITPRIPL2andSYT17, variant not shown         Submitted on the opposite strand    
F04792 brain, total brain Gene ITPRIPL2andSYT17, variant not shown         This clone was ignored    
F08582 brain, total brain Gene ITPRIPL2andSYT17, variant not shown         This clone was ignored    
BE091601 breast Gene ITPRIPL2andSYT17, variant not shown         Suspected internal deletion, this clone was ignored    
DB544528 hippocampus Gene ITPRIPL2andSYT17, variant not shown         Submitted on the opposite strand    
BM680503 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid Gene ITPRIPL2andSYT17, variant not shown         Suspected internal deletion, this clone was ignored    
BM718052 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid Gene ITPRIPL2andSYT17, variant not shown         Suspected internal deletion, this clone was ignored    
BM973871 lung Gene ITPRIPL2andSYT17, variant not shown       AAA This clone was ignored    
DB547080 hippocampus Gene ITPRIPL2andSYT17, variant not shown         Submitted on the opposite strand    
BE814541 breast_normal Gene ITPRIPL2andSYT17, variant not shown         This clone was ignored    
DB538418 hippocampus Gene ITPRIPL2andSYT17, variant not shown         Submitted on the opposite strand    
CA439023 lung, Lung Focal Fibrosis Gene ITPRIPL2andSYT17, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
BP208819 cerebellum Gene ITPRIPL2andSYT17, variant not shown         Suspected internal deletion, this clone was ignored    
DB539805 hippocampus Gene ITPRIPL2andSYT17, variant not shown         Submitted on the opposite strand    
DC318799 brain Gene ITPRIPL2andSYT17, variant not shown         This clone was ignored    
DC425849 brain Gene ITPRIPL2andSYT17, variant not shown         This clone was ignored    
EL946280 eyeball Gene ITPRIPL2andSYT17, variant not shown         Submitted on the opposite strand    
AK226136 brain Gene ITPRIPL2andSYT17, variant not shown       AAA Suspected internal deletion, this clone was ignored    
DC338670 subthalamic nucleus Gene ITPRIPL2andSYT17, variant not shown         Suspected internal deletion, this clone was ignored    
DB313490 tongue, tumor tissue Gene ITPRIPL2andSYT17, variant not shown         This clone was ignored    
DA437998 tongue, tumor tissue Gene ITPRIPL2andSYT17, variant not shown       capped This clone was ignored    
R53046 whole brain Gene ITPRIPL2andSYT17, variant not shown         This clone was ignored    
AA865596 pooled germ cell tumors Gene ITPRIPL2andSYT17, variant not shown         This clone was ignored    
AI198391 anaplastic oligodendroglioma, brain Gene ITPRIPL2andSYT17, variant not shown         This clone was ignored    
AI582818 anaplastic oligodendroglioma, brain Gene ITPRIPL2andSYT17, variant not shown         This clone was ignored    
TI_149291131   Gene ITPRIPL2andSYT17, variant not shown       AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c-u, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q-u, .r-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI